Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences:
- Wells Fargo Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings and fireside chat on September 8 at 3:45 pm Eastern Time (ET) in Boston, MA.
- Citi’s Biopharma Back to School Summit: Zymeworks’ management will participate in one-on-one meetings and fireside chat on September 9 at 3:40 pm ET in New York, NY.
- Morgan Stanley Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings and fireside chat on September 14 at 4:50 pm ET in New York, NY.
- H.C. Wainwright Annual Global Investment Conference: Zymeworks’ management will participate in one-on-one meetings and a fireside chat on September 15 in New York, NY.
About Zymeworks Inc.
Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks’ asset and royalty aggregation strategy focuses on optimizing positive future cash flows from an emerging portfolio of licensed products such as Ziihera® (zanidatamab-hrii) and other licensed products and product candidates, such as pasritamig. In addition, Zymeworks is also building a portfolio of healthcare assets that can generate strong cash flows, while supporting the development of innovative medicines. Zymeworks engineered and developed Ziihera, a HER2-targeted bispecific antibody using Zymeworks’ proprietary Azymetric™ technology and has entered into separate agreements with BeOne Medicines Ltd. (formerly BeiGene, Ltd.) and Jazz Pharmaceuticals Ireland Limited granting each exclusive rights to develop and commercialize zanidatamab in different territories. Zymeworks is rapidly advancing a robust pipeline of product candidates, leveraging its expertise in both antibody drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. Zymeworks’ complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutics. These capabilities have been further leveraged through strategic partnerships with global biopharmaceutical companies. For information about Zymeworks, visit www.zymeworks.com and follow @ZymeworksInc on X.
Contacts:
Investor Inquiries:
Shrinal Inamdar
Vice President, Investor Relations
(604) 678-1388
ir@zymeworks.com
Media Inquiries:
Diana Papove
Vice President, Corporate Communications
(604) 678-1388
media@zymeworks.com
- 五一趣游福州 鼓山鼓岭双景齐出彩
- Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates
- WeRide Accelerates Global Expansion of Its End-to-End Intelligent Driving Solution
- 聚焦亚太地区另类资产市场,日本印度日渐受投资者追捧 — Preqin报告
- 穹彻智能工业交付能力中心签约落地无锡,打造更强“大脑”
- 家电出口势头强劲 长虹美菱用“新”出海
- HERE Technologies and Amap form Strategic Alliance to Deliver Next-Gen AI Navigation for Chinese Aut
- 门业网打造行业新生态,赋能门窗智能升级!
- 创新实业今起招股 入场费约5550港元
- 东莞莞南皮肤病专科如何?以实力打造良好口碑
- Coventry CEO Reid Buerger Recognized by Finseca as 2025 ID Twenty Honoree at NAILBA 44
- 杭州天目山医院耳鼻喉科:深耕专业领域,铸就耳鼻喉健康“守护者”
- World Bicycle Day: Experience Denmark through Danish Wheelness™
- 车市价格战后遗症:前11个月损失1776亿元
- 幸福觉醒之旅佛山站新闻发布会启航
- 东芝发布采用高速二极管的功率MOSFET,可助提高电源的效率
- 照亮知识产权强国征途的璀璨之光 ——读《老大之路》有感
- Venture Global关于Shell仲裁裁决的声明
- 新渠道,大买家!休闲零食人的专属盛会,SSE国际休食展即将启幕!
- 越捷航空2024年再度荣登“越南50强上市公司”榜单
- 厨房让人欲哭无泪?A.O.史密斯「瀞」油烟机解决厨房痛点,助推生活品质升级
- FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US
- 邓为穿着连卡佛春夏新品,演绎早春绅士型格
- Monaco Classic Week Sets Sail with 160 Boats and a Touch of Cinema
- SymphonyAI Launches Sensa Risk Intelligence to Modernize Financial Compliance With Proven AI Experti
- Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-qualit
- 瑞众保险广东分公司中山中支:旗袍摄影映非遗,宋锦DIY添雅趣
- 加盟热潮!壹馆佳养生馆安徽连锁模式获认可,创业者争相入局
- 长发小寨携手金穗奖:以非遗智慧与AI势能共绘乡村振兴新图景
- 中裕科技2025年营收同比增长18.41%





